期刊
PLANTA MEDICA
卷 77, 期 9, 页码 894-899出版社
GEORG THIEME VERLAG KG
DOI: 10.1055/s-0030-1250627
关键词
Rhodiola crenulata (Hook. f. et Thoms.) H. Ohba; Crassulaceae; hypoxia-inducible factor; erythropoietin
资金
- Research Grants Council of Hong Kong [HKUST 6419/06M, N_HKUST629/07, 662608, 661110]
- Croucher Foundation [CAS-CF07/08.SC03]
Rhodiolae Crenulatae Radix et Rhizoma (Rhodiola), the root and rhizome of Rhodiola crenulata (Hook. f. et Thoms.) H. Ohba, has been used as a traditional Chinese medicine (TCM) to increase the body resistance against hypoxia in mountain sickness. The mechanism of this adaptogenic property deriving from Rhodiola, however, has not been revealed. Erythropoietin (EPO) is an erythrocyte-specific hematopoietic hormone that increases the production of red blood cells: this hormone is a crucial factor in regulating the body balance in responding to hypoxia. In cultured kidney fibroblasts (HEK293T), application of water extract deriving from Rhodiola induced the expression of EPO both in mRNA and protein levels. The activation of the hypoxia response element (HRE) located on the promoter region of the EPO gene is one of the mechanisms accounting for transcriptional activation. In addition, the Rhodiola-induced EPO expression was triggered by an increase of hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein, via the reduction of HIF-1 alpha degradation but not the induction of HIF-1 alpha mRNA. Moreover, the same EPO induction effect by Rhodiola was also observed in cultured liver cells since liver is another vital organ to provide EPO regulation apart from the kidney. These results therefore elucidate one of the molecular mechanisms of this herb in mediating the anti-hypoxia function.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据